The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy

Gabriella Moroni, Silvana Quaglini, Antonella Radice, Barbara Trezzi, Francesca Raffiotta, Piergiorgio Messa, Renato Alberto Sinico

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Few studies have correlated serum biomarkers with renal histology, the gold standard for renal activity, in lupus nephritis (LN). We tested a panel of autoantibodies and complement at the time of kidney biopsy and after treatment. Anti-dsDNA, anti-nucleosome, anti-ribosome P, and anti-C1q antibodies and C3/C4 were measured in 107 patients with LN at the time of renal biopsy and after 6-12 months and were correlated with clinical/histological parameters. At multivariate analysis, high titers of anti-C1q antibodies or of anti-dsDNA antibodies (P = 0.005, OR = 8.67, CI: 2.03-37.3) were the independent predictors that discriminate proliferative from nonproliferative LN. All the immunological parameters, except anti-ribosome, showed a significant correlation with activity index but not with chronicity index. Only anti-C1q showed a significant correlation with the amount of proteinuria (R = 0.2, P = 0.03). None of the immunological parameters were predictive of remission at 6 and 12 months. We found that anti-C1q alone or in combination with anti-dsDNA emerged as the most reliable test in differentiating proliferative and nonproliferative LN. Anti-C1q was the only test correlated with the clinical presentation of LN. After treatment, the titre of the autoantibodies was significantly reduced, but none was predictive of remission.

Original languageEnglish
Article number106904
JournalJournal of Immunology Research
Volume2015
DOIs
Publication statusPublished - Feb 26 2015

Fingerprint

Lupus Nephritis
Autoantibodies
Kidney
Biopsy
Anti-Idiotypic Antibodies
Ribosomes
Nucleosomes
Proteinuria
Histology
Multivariate Analysis
Biomarkers
Therapeutics
Serum

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy. / Moroni, Gabriella; Quaglini, Silvana; Radice, Antonella; Trezzi, Barbara; Raffiotta, Francesca; Messa, Piergiorgio; Sinico, Renato Alberto.

In: Journal of Immunology Research, Vol. 2015, 106904, 26.02.2015.

Research output: Contribution to journalArticle

Moroni, Gabriella ; Quaglini, Silvana ; Radice, Antonella ; Trezzi, Barbara ; Raffiotta, Francesca ; Messa, Piergiorgio ; Sinico, Renato Alberto. / The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy. In: Journal of Immunology Research. 2015 ; Vol. 2015.
@article{3ce56142fdd94b6c8f2289663ae01c69,
title = "The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy",
abstract = "Few studies have correlated serum biomarkers with renal histology, the gold standard for renal activity, in lupus nephritis (LN). We tested a panel of autoantibodies and complement at the time of kidney biopsy and after treatment. Anti-dsDNA, anti-nucleosome, anti-ribosome P, and anti-C1q antibodies and C3/C4 were measured in 107 patients with LN at the time of renal biopsy and after 6-12 months and were correlated with clinical/histological parameters. At multivariate analysis, high titers of anti-C1q antibodies or of anti-dsDNA antibodies (P = 0.005, OR = 8.67, CI: 2.03-37.3) were the independent predictors that discriminate proliferative from nonproliferative LN. All the immunological parameters, except anti-ribosome, showed a significant correlation with activity index but not with chronicity index. Only anti-C1q showed a significant correlation with the amount of proteinuria (R = 0.2, P = 0.03). None of the immunological parameters were predictive of remission at 6 and 12 months. We found that anti-C1q alone or in combination with anti-dsDNA emerged as the most reliable test in differentiating proliferative and nonproliferative LN. Anti-C1q was the only test correlated with the clinical presentation of LN. After treatment, the titre of the autoantibodies was significantly reduced, but none was predictive of remission.",
author = "Gabriella Moroni and Silvana Quaglini and Antonella Radice and Barbara Trezzi and Francesca Raffiotta and Piergiorgio Messa and Sinico, {Renato Alberto}",
year = "2015",
month = "2",
day = "26",
doi = "10.1155/2015/106904",
language = "English",
volume = "2015",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Limited",

}

TY - JOUR

T1 - The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy

AU - Moroni, Gabriella

AU - Quaglini, Silvana

AU - Radice, Antonella

AU - Trezzi, Barbara

AU - Raffiotta, Francesca

AU - Messa, Piergiorgio

AU - Sinico, Renato Alberto

PY - 2015/2/26

Y1 - 2015/2/26

N2 - Few studies have correlated serum biomarkers with renal histology, the gold standard for renal activity, in lupus nephritis (LN). We tested a panel of autoantibodies and complement at the time of kidney biopsy and after treatment. Anti-dsDNA, anti-nucleosome, anti-ribosome P, and anti-C1q antibodies and C3/C4 were measured in 107 patients with LN at the time of renal biopsy and after 6-12 months and were correlated with clinical/histological parameters. At multivariate analysis, high titers of anti-C1q antibodies or of anti-dsDNA antibodies (P = 0.005, OR = 8.67, CI: 2.03-37.3) were the independent predictors that discriminate proliferative from nonproliferative LN. All the immunological parameters, except anti-ribosome, showed a significant correlation with activity index but not with chronicity index. Only anti-C1q showed a significant correlation with the amount of proteinuria (R = 0.2, P = 0.03). None of the immunological parameters were predictive of remission at 6 and 12 months. We found that anti-C1q alone or in combination with anti-dsDNA emerged as the most reliable test in differentiating proliferative and nonproliferative LN. Anti-C1q was the only test correlated with the clinical presentation of LN. After treatment, the titre of the autoantibodies was significantly reduced, but none was predictive of remission.

AB - Few studies have correlated serum biomarkers with renal histology, the gold standard for renal activity, in lupus nephritis (LN). We tested a panel of autoantibodies and complement at the time of kidney biopsy and after treatment. Anti-dsDNA, anti-nucleosome, anti-ribosome P, and anti-C1q antibodies and C3/C4 were measured in 107 patients with LN at the time of renal biopsy and after 6-12 months and were correlated with clinical/histological parameters. At multivariate analysis, high titers of anti-C1q antibodies or of anti-dsDNA antibodies (P = 0.005, OR = 8.67, CI: 2.03-37.3) were the independent predictors that discriminate proliferative from nonproliferative LN. All the immunological parameters, except anti-ribosome, showed a significant correlation with activity index but not with chronicity index. Only anti-C1q showed a significant correlation with the amount of proteinuria (R = 0.2, P = 0.03). None of the immunological parameters were predictive of remission at 6 and 12 months. We found that anti-C1q alone or in combination with anti-dsDNA emerged as the most reliable test in differentiating proliferative and nonproliferative LN. Anti-C1q was the only test correlated with the clinical presentation of LN. After treatment, the titre of the autoantibodies was significantly reduced, but none was predictive of remission.

UR - http://www.scopus.com/inward/record.url?scp=84924546174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924546174&partnerID=8YFLogxK

U2 - 10.1155/2015/106904

DO - 10.1155/2015/106904

M3 - Article

C2 - 25815344

AN - SCOPUS:84924546174

VL - 2015

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

M1 - 106904

ER -